BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17530866)

  • 1. Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.
    Pownall HJ; Hosken BD; Gillard BK; Higgins CL; Lin HY; Massey JB
    Biochemistry; 2007 Jun; 46(25):7449-59. PubMed ID: 17530866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling of human plasma lipoproteins by detergent perturbation.
    Pownall HJ
    Biochemistry; 2005 Jul; 44(28):9714-22. PubMed ID: 16008356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.
    Tian L; Wu J; Fu M; Xu Y; Jia L
    Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ethylene glycol)-induced fusion and destabilization of human plasma high-density lipoproteins.
    Jayaraman S; Gantz DL; Gursky O
    Biochemistry; 2004 May; 43(18):5520-31. PubMed ID: 15122918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of apolipoproteins A-I and A-II in plasma HDL remodeling].
    Wróblewska M
    Postepy Biochem; 2009; 55(3):315-22. PubMed ID: 19928588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma factors required for human apolipoprotein A-II dimerization.
    Gillard BK; Chen YS; Gaubatz JW; Massey JB; Pownall HJ
    Biochemistry; 2005 Jan; 44(2):471-9. PubMed ID: 15641771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bezafibrate on HDL with APO A-I and APO A-II and on HDL with APO A-I without APO A-II in hyperlipidaemic patients.
    Branchi A; Rovellini A; Sommariva D
    Int J Clin Pharmacol Res; 1995; 15(4):153-8. PubMed ID: 8871265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-enzymatic glycosylation of apolipoprotein A-I and its functional consequences.
    Fiévet C; Igau B; Bresson R; Drouin P; Fruchart JC
    Diabete Metab; 1995 Apr; 21(2):95-8. PubMed ID: 7621978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs.
    Briand F; Magot T; Krempf M; Nguyen P; Ouguerram K
    Eur J Clin Invest; 2006 Apr; 36(4):224-30. PubMed ID: 16620283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of weight reduction on the distribution of apolipoprotein A-I in high-density lipoprotein subfractions in obese non-insulin-dependent diabetic subjects.
    Shige H; Nestel P; Sviridov D; Noakes M; Clifton P
    Metabolism; 2000 Nov; 49(11):1453-9. PubMed ID: 11092511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Displacement of apo A-I by A-II in lipid-apoprotein complexes and human HDL.
    Rosseneu M; Van Tornout P; Caster H; Lievens MJ
    Acta Cardiol Suppl; 1981; 27():11-29. PubMed ID: 6801887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
    Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
    Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of salt on the thermal stability of human plasma high-density lipoprotein.
    Jayaraman S; Gantz DL; Gursky O
    Biochemistry; 2006 Apr; 45(14):4620-8. PubMed ID: 16584197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unique role of apolipoprotein A-I in HDL remodeling and metabolism.
    Pownall HJ; Ehnholm C
    Curr Opin Lipidol; 2006 Jun; 17(3):209-13. PubMed ID: 16680023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of prebeta1 HDL and alphaHDL in type II diabetic patients.
    Chétiveaux M; Lalanne F; Lambert G; Zair Y; Ouguerram K; Krempf M
    Eur J Clin Invest; 2006 Jan; 36(1):29-34. PubMed ID: 16403007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of mixed micelles and vesicles of human apolipoproteins A-I and A-II with synthetic and natural lecithins and the bile salt sodium taurocholate: quasi-elastic light scattering studies.
    Donovan JM; Benedek GB; Carey MC
    Biochemistry; 1987 Dec; 26(25):8215-33. PubMed ID: 3126801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular processing of HDL by the liver during reverse cholesterol transport.
    Mayes PA; Mindham MA
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():147-8. PubMed ID: 8767494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal HDL-apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy.
    Toledo-Ibelles P; Franco M; Carreón-Torres E; Luc G; Tailleux A; Vargas-Alarcón G; Fragoso JM; Aguilar-Salinas C; Luna-Luna M; Pérez-Méndez O
    Metabolism; 2013 Apr; 62(4):492-8. PubMed ID: 23089050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients.
    Cho KH; Park SH; Park JE; Kim YO; Choi I; Kim JJ; Kim JR
    Clin Biochem; 2008 Jan; 41(1-2):56-64. PubMed ID: 17996200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brazil nut ingestion increased plasma selenium but had minimal effects on lipids, apolipoproteins, and high-density lipoprotein function in human subjects.
    Strunz CC; Oliveira TV; Vinagre JC; Lima A; Cozzolino S; Maranhão RC
    Nutr Res; 2008 Mar; 28(3):151-5. PubMed ID: 19083402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.